Biopharmaceutical innovation: the complexity of the R&D process
Share
Presentation by Dr. Markus Boehringer, Head of External Innovation & Alliances CVM Diseases, F. Hoffmann-La Roche. Geneva Pharma Forum on Biopharmaceutical Innovation. 17 April 2012 at WIPO
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.
Learn more
Related news and resources
Collaborating to achieve universal health coverage
Explore how the innovative pharmaceutical industry is partnering to ensure innovation and access contribute to global health progress and improve lives everywhere in this report. The Sustainable Development Goals (SDGs) explicitly strive to engage the private sector in addressing the world’s most pressing challenges and emphasize the importance of cross-sector collaborations. Universal Health Coverage (UHC)...
Read more
Collaborating to achieve universal health coverage
Discover how the innovative pharmaceutical industry is embracing partnerships to accelerate action on SDG 3 and other global goals in this infographic.
Read more
No-Fault Compensation (NFC) systems and legislative liability protections for pandemic vaccines
This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.
Read more